Sep 12, 2014
National Institute on Drug Abuse (NIDA/NIH)
Opioid-related disorders > Morphine dependence; Gambling;
Nonfatal ED visits for alcohol or other drug diagnoses
California, annual average, 2012-2014
https://www.chcf.org/publication/2018-edition-substance-use-california
2018 Edition — Substance Use in California
A look at addiction and treatment
October 3, 2018
Wendy Holt, DMA Health Strategies
Delay Discounting
December 7, 2015
https://medicine.wustl.edu/news/podcast/delay-discounting
Dr. Schneekloth: You know, well, ultimately there needs to be the choice that one wants to stop. But that’s often when the pressure increases to a point that there seem no alternatives.
…, but ultimately the decision needs to be made by the one with the addiction: Are they going to stop?
Now, some people can stop on their own. As a matter of fact, the majority of alcoholics stop, never receive addiction treatment, go on to do well. There are different types, though, and some have more severe forms of addiction and need multiple treatments.
… there are repeated exacerbations of the illness, that it comes back. And in the same way with addiction, relapse is often a part of it. Now, families can feel like that’s somehow a failure, but often one treatment builds on another and eventually leads, like Nicolas’ story, to ongoing recovery.
Dr. Pamela Peeke is an internationally renowned physician, scientist and exper t in the fields of nutrition, metabolism, stress and fitness. Triathlete and marathoner, Dr. Peeke is nationally known as the “doc who walks the talk” inspiring through example. Dr. Peeke is the lifestyle exper t for WebMD’s 90 million members, and a regular blogger on cutting edge science in health and wellness. Presently, Dr. Peeke is Senior Science Advisor to Elements Behavioral Health, the nation’s most preeminent network of eating disorders and addiction centers. Her current research focuses on how addictive behaviors have subtly and often profoundly penetrated daily lifestyle habits.
related:
https://franzcalvo.wordpress.com/2017/04/30/no-one-will-truly-invest-in
Dopamine Receptor Agonist Drugs and Impulse Control Disorders
JAMA Intern Med. October 20, 2014
http://archinte.jamanetwork.com/article.aspx?articleid=1916907
The discovery of striatal dopamine deficiency and the introduction of levodopa in the 1960s as treatment for the motor symptoms of Parkinson disease revolutionized neurology and neurotherapeutics.
For the first time, patients with an apparently hopeless chronic degenerative brain disorder were able to regain function and return to the mainstream of life.
Levodopa was subsequently combined with carbidopa, as the latter prevented the adverse effects associated with peripheral dopamine synthesis without blocking central dopamine synthesis.
journalistic version:
http://www.npr.org/blogs/health/2014/10/20/357586341/parkinsons-drugs-can-be-a-gateway-to-sin
how by its nature the human brain is susceptible to the effects of addictive substances.
cited by:
Learning How to Learn
by University of California, San Diego
on Coursera.